0 Évaluations
ID

14140

Description

Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01509755

Lien

https://clinicaltrials.gov/show/NCT01509755

Mots-clés

Versions (1)
  1. 31/03/2016 31/03/2016 -
Téléchargé le

31 mars 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Diabetes NCT01509755

    Anglais

    Eligibility Diabetes NCT01509755

    1 Formulaires  
    1. StudyEvent: Eligibility
      1. Eligibility Diabetes NCT01509755
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    subjects with type 2 diabetes
    Description

    Type 2 Diabetes

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0011860
    duration of diabetes at least 3 months
    Description

    Duration of Diabtes

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0872146
    UMLS CUI [1,2]
    C0011860
    both diet treated and patients in therapy with oha (oral hypoglycemic agents)
    Description

    Diabetic diet and oral hypoglycemic agents

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0011878
    UMLS CUI [2]
    C0359086
    body mass index maximum 40 kg/m^2
    Description

    Body mass index

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1305855
    hba1c based on analysis from central laboratory: between 7.5-10.0%, both inclusive, for diet treated, or maximum 9.0% for oha treated
    Description

    Hba1c

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0019018
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    liver or renal disease
    Description

    Liver or renal disease

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0023895
    UMLS CUI [2]
    C0022658
    cardiac problems
    Description

    Cardiac problems

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0262402
    uncontrolled treated/untreated hypertension
    Description

    Hypertension

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0020538
    proliferative retinopathy
    Description

    Proliferative retinopathy

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0339467
    recurrent severe hypoglycaemia as judged by the investigator
    Description

    Recurrent severe hypoglycaemia

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0342316
    known or suspected allergy to trial product or related products
    Description

    Allergy to trial product

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C3854006
    use of any drug (except for ohas) which in the investigator's opinion could interfere with the blood glucose level
    Description

    Pharmacotherapy interferes with blood glucose level

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0013216
    UMLS CUI [1,2]
    C0521102
    UMLS CUI [1,3]
    C0392201
    Retour au début de la page

    Similar models

    Eligibility Diabetes NCT01509755

    1 Formulaires
    1. StudyEvent: Eligibility
      1. Eligibility Diabetes NCT01509755
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Type 2 Diabetes
    Item
    subjects with type 2 diabetes
    boolean
    C0011860 (UMLS CUI [1])
    Duration of Diabtes
    Item
    duration of diabetes at least 3 months
    boolean
    C0872146 (UMLS CUI [1,1])
    C0011860 (UMLS CUI [1,2])
    Diabetic diet and oral hypoglycemic agents
    Item
    both diet treated and patients in therapy with oha (oral hypoglycemic agents)
    boolean
    C0011878 (UMLS CUI [1])
    C0359086 (UMLS CUI [2])
    Body mass index
    Item
    body mass index maximum 40 kg/m^2
    boolean
    C1305855 (UMLS CUI [1])
    Hba1c
    Item
    hba1c based on analysis from central laboratory: between 7.5-10.0%, both inclusive, for diet treated, or maximum 9.0% for oha treated
    boolean
    C0019018 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Liver or renal disease
    Item
    liver or renal disease
    boolean
    C0023895 (UMLS CUI [1])
    C0022658 (UMLS CUI [2])
    Cardiac problems
    Item
    cardiac problems
    boolean
    C0262402 (UMLS CUI [1])
    Hypertension
    Item
    uncontrolled treated/untreated hypertension
    boolean
    C0020538 (UMLS CUI [1])
    Proliferative retinopathy
    Item
    proliferative retinopathy
    boolean
    C0339467 (UMLS CUI [1])
    Recurrent severe hypoglycaemia
    Item
    recurrent severe hypoglycaemia as judged by the investigator
    boolean
    C0342316 (UMLS CUI [1])
    Allergy to trial product
    Item
    known or suspected allergy to trial product or related products
    boolean
    C0020517 (UMLS CUI [1,1])
    C3854006 (UMLS CUI [1,2])
    Pharmacotherapy interferes with blood glucose level
    Item
    use of any drug (except for ohas) which in the investigator's opinion could interfere with the blood glucose level
    boolean
    C0013216 (UMLS CUI [1,1])
    C0521102 (UMLS CUI [1,2])
    C0392201 (UMLS CUI [1,3])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial